Concepedia

Steven Glass

SG

6

Publications

301

Citations

6

H-Index

1985

Active since

Affiliations

Intra Cellular Therapies (United States)(Current)

Steven Glass is an author at Intra Cellular Therapies (United States) specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

MedicinePsychiatryPharmacologySchizophreniaDrug DiscoveryPharmacotherapyPsychopathologySocial SciencesBiological PsychiatryAnesthesia

Publications per year

1985–2019

6

Publications

6

Mifepristone versus Placebo in the Treatment of Psychosis in Patients with Psychotic Major Depression

Charles DeBattista, Joseph K. Belanoff, Steven Glass et al. · Biological Psychiatry · 2006 · 159 citations

Psychopathology, Mifepristone Versus Placebo, Psychiatry +12

Adjunctive Modafinil at Initiation of Treatment With a Selective Serotonin Reuptake Inhibitor Enhances the Degree and Onset of Therapeutic Effects in Patients With Major Depressive Disorder and Fatigue

Philip T. Ninan, Howard A Hassman, Steven Glass et al. · The Journal of Clinical Psychiatry · 2004 · 73 citations

Effects of histamine-2 receptor blockade on lidocaine kinetics

J. Edward Jackson, John B. Bentley, Steven Glass et al. · Clinical Pharmacology & Therapeutics · 1985 · 29 citations

Molecular Pharmacology, Anaesthetic Agent, Pharmacological Study +15

S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY

Kimberly E. Vanover, Alex Dmitrienko, Steven Glass et al. · Schizophrenia Bulletin · 2018 · 17 citations · Full text

Psychoactive Drug, Psychiatry, Psychotic Disorder +15

S117. FAVORABLE LONG-TERM SAFETY PROFILE OF LUMATEPERONE IITI-007): RESULTS FROM A 12 MONTH OPEN LABEL SAFETY STUDY FOR LUMATEPERONE IN PATIENTS WITH STABLE SYMPTOMS OF SCHIZOPHRENIA

Kimberly E. Vanover, Andrew Satlin, Saresh Durgam et al. · Schizophrenia Bulletin · 2019 · 12 citations · Full text

Rows per page

1–5 of 6